全文获取类型
收费全文 | 9092篇 |
免费 | 557篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 210篇 |
妇产科学 | 111篇 |
基础医学 | 1281篇 |
口腔科学 | 30篇 |
临床医学 | 861篇 |
内科学 | 2331篇 |
皮肤病学 | 118篇 |
神经病学 | 755篇 |
特种医学 | 366篇 |
外科学 | 1655篇 |
综合类 | 23篇 |
一般理论 | 2篇 |
预防医学 | 373篇 |
眼科学 | 75篇 |
药学 | 585篇 |
中国医学 | 22篇 |
肿瘤学 | 840篇 |
出版年
2023年 | 52篇 |
2022年 | 92篇 |
2021年 | 230篇 |
2020年 | 122篇 |
2019年 | 242篇 |
2018年 | 244篇 |
2017年 | 194篇 |
2016年 | 199篇 |
2015年 | 266篇 |
2014年 | 328篇 |
2013年 | 421篇 |
2012年 | 705篇 |
2011年 | 727篇 |
2010年 | 412篇 |
2009年 | 388篇 |
2008年 | 592篇 |
2007年 | 624篇 |
2006年 | 590篇 |
2005年 | 665篇 |
2004年 | 564篇 |
2003年 | 539篇 |
2002年 | 556篇 |
2001年 | 72篇 |
2000年 | 54篇 |
1999年 | 90篇 |
1998年 | 121篇 |
1997年 | 75篇 |
1996年 | 69篇 |
1995年 | 46篇 |
1994年 | 60篇 |
1993年 | 52篇 |
1992年 | 22篇 |
1991年 | 25篇 |
1990年 | 31篇 |
1989年 | 17篇 |
1988年 | 20篇 |
1987年 | 20篇 |
1986年 | 13篇 |
1985年 | 13篇 |
1984年 | 14篇 |
1983年 | 13篇 |
1982年 | 12篇 |
1981年 | 16篇 |
1980年 | 11篇 |
1979年 | 12篇 |
1976年 | 9篇 |
1975年 | 6篇 |
1973年 | 7篇 |
1972年 | 7篇 |
1971年 | 5篇 |
排序方式: 共有9693条查询结果,搜索用时 0 毫秒
71.
72.
Stéphanie Oger Delphine Behr-Roussel Diane Gorny Olivier Lecoz Thierry Lebret Yves Denoux Antoine Faix Albert Leriche Chris Wayman Laurent Alexandre François Giuliano 《The journal of sexual medicine》2009,6(3):836-847
IntroductionPhosphodiesterase 5 inhibitors (PDE5) such as sildenafil are first-line treatment for erectile dysfunction (ED). Alpha1 (α1)-adrenoceptor antagonists such as doxazosin are indicated for the treatment of patients with lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH). ED and LUTS/BPH are conditions that are often associated. Accordingly, α1-adrenoceptor antagonists and PDE5 inhibitors will be often prescribed in real life setting together.AimTo evaluate the effects of the combination of sildenafil and doxazosin on human cavernosal and prostatic tissue.MethodsProstatic and erectile tissues were obtained from nine to 12 patients, respectively. Patients underwent cystoprostatectomy for infiltrating bladder cancer or penile surgery for penile implant, congenital curvature or Peyronie's disease.Main Outcome MeasuresIn organ baths, prostatic and cavernosal strips were submitted to either concentration-response curves (CRC) to phenylephrine (Phe) or norepinephrine (NE), respectively, in presence of vehicle, sildenafil (10?6 M, 10?5 M), doxazosin (10?8 M, 3.10?8 M, or 10?7 M), or a combination of both. Continuous electrical field stimulation (EFS; 32 Hz, 5 ms, 5 seconds, 300 mA) was performed on prostatic strips which were incubated with sildenafil 10?6 M or vehicle before the successive addition of doxazosin (10?7 M, 10?6 M) or vehicle. Cavernosal strips were pre-incubated with doxazosin (10?9 M, 10?8 M) or vehicle, then CRC to sildenafil were constructed on NE (3.10?6 M) precontracted cavernosal strips.ResultsCombination of sildenafil and doxazosin exerted a greater relaxing effect on CRC to Phe or NE compared with each compound alone in both tissues. Sildenafil significantly enhanced the relaxing effect of doxazosin on EFS-induced contractions in prostatic strips. Doxazosin significantly increased the ability of sildenafil to inhibit NE-induced contractions in cavernosal strips.ConclusionsSildenafil and doxazosin reduced adrenergic tone of prostatic and cavernosal smooth muscle and their combination provided a significant benefit when targeting relaxation of both tissues. These experiments provide support for further clinical evaluation of the sildenafil and doxazosin combination in ED patients with LUTS/BPH. Oger S, Behr-Roussel D, Gorny D, Lecoz O, Lebret T, Denoux Y, Faix A, Leriche A, Wayman C, Alexandre L, and Giuliano F. Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue. J Sex Med 2009;6:836–847. 相似文献
73.
Philippe Lévy Arnaud Boruchowicz Patrick Hastier Alexandre Pariente Thierry Thévenot Jean Louis Frossard Louis Buscail Fran?ois Mauvais Jean Claude Duchmann Alain Courrier Philippe Bulois Jean Louis Gineston Marc Barthet Henri Licht Dermot O'Toole Philippe Ruszniewski 《Pancreatology》2005,5(4-5):450-456
BACKGROUND: No study on bioclinical criteria predicting a biliary origin for acute pancreatitis has included endosonography as a reference examination. Re-examination of bioclinical parameters deserves consideration in the era where other causes are known (e.g. hereditary, autoimmune). AIM AND METHODS: To determine the performance of bioclinical markers in predicting a biliary origin of acute pancreatitis where the diagnosis of biliary lithiasis was established or ruled out using endosonography. Only patients with a first acute episode of pancreatitis were included. RESULTS: 213 patients (male: 55%; median age: 56 years) were prospectively included in 14 centres. Causes of acute pancreatitis were: biliary (62%), alcoholic (25%), other (13%). Delay between symptom-onset and admission was <48 h in 80%. Endosonography was the sole method establishing the diagnosis of biliary pancreatitis in 15% of patients. At univariate analysis, age, female sex, declared alcohol consumption, elevated aspartate and alanine transaminases on admission, gammaglutamyl transferase, alkaline phosphatase, total bilirubin, lipase, mean corpuscular volume were predictive of a biliary origin. Only age (p < 0.0001), sex (p < 0.0008) and alanine transaminase (p < 0.0004) remained significant at multivariate analysis. At age 50, the respective sensitivity and specificity were 73 and 65%. With an elevated alanine transaminase at 2 times the upper limit of normal range, the respective sensitivity and specificity were 74 and 84%. The probability of a biliary origin of acute pancreatitis could be estimated by the following formula: = 1/1 + exp(4.6967 - 0.0656 x age + 1.1208 x sex - 0.6909 x alanine transaminase). CONCLUSION: When endosonography is performed to confirm or exclude a biliary origin of acute pancreatitis, age, sex and alanine transaminase at admission are the only factors predictive of a biliary cause. 相似文献
74.
75.
76.
77.
Mignot A Bridoux F Thierry A Varnous S Pujo M Delcourt A Gombert JM Goujon JM Favreau F Touchard G Herpin D Jaccard A 《Haematologica》2008,93(3):e32-e35
Recurrence in the allograft and progression in other organs increase mortality after cardiac transplantation in AL amyloidosis. Survival may be improved after suppression of monoclonal light chain (LC) production following high dose melphalan and autologous stem cell transplantation (HDM/ASCT). However, because of high treatment related mortality, this tandem approach is restricted to few patients without significant extra-cardiac involvement. A diagnosis of systemic AL amyloidosis was established in a 45-year old patient with congestive heart failure related to restrictive cardiomyopathy, nephrotic syndrome, peripheral neuropathy, postural hypotension, macroglossia, and lambda LC monoclonal gammopathy. After melphalan and dexamethasone (M-Dex) therapy, which resulted in 80% reduction of serum free lambda LC, he underwent orthotopic cardiac transplantation. Two years later, he remains in a sustained hematologic remission, with no evidence of allograft or extra-cardiac amyloid accumulation. M-Dex should be considered as an alternative therapy in AL amyloid heart transplant recipients ineligible for HDM/ASCT. 相似文献
78.
79.
80.
Nimalan Arinaminpathy Thierry Cordier-Lassalle Kaspars Lunte Christopher Dye 《Bulletin of the World Health Organization》2015,93(4):237-248A